IncFact
Company Profiles: Revenue, Growth, Competition

SERES THERAPEUTICS Revenue, Growth & Competitor Profile

DBA SERES HEALTH, INC.
Last updated:

Company Awards

 
Public Company
public company
Fast Growing
Fastest Growing
Big Fish
Big Fish
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Seres Therapeutics

Access the complete profile.

Seres Therapeutics Fast Facts

Revenue$100 - $500 million    See Exact Annual Revenue
Employees100 - 500Exact Company Size
Primary Industry517 Telecommunications
Additional NAICS Codes541714
Address200 Sidney Street
Cambridge, MA 02139

sereshealth.com


Seres Therapeutics's annual revenues are $100-$500 million (see exact revenue data) and has 100-500 employees. It is classified as operating in the Telecommunications industry.


Seres Therapeutics's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Seres Therapeutics is a publicly traded company on NMS using the ticker symbol MCRB. Detailed information on company financials and operating reports can be found here: NMS: MCRB



Seres Therapeutics Annual Revenue and Growth Rate

Seres Therapeutics Revenue Est.
($ Million)
Growth Rate (%)# Employees
2023 Details in Premium Report
2022
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Seres Therapeutics's revenues are gauged from an analysis of company filings.



Investor Activity

Seres Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
January 5, 2015 1 100%$65 MM
Complete list of funding rounds and total amounts in the Company Report




Trademark Applications

Trademark applications show the products and services that Seres Therapeutics is developing and marketing. Seres Therapeutics's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
VOWST VOYAGE
Educational services, namely, conducting educational programs in the fields of dysbiosis and other medical conditions resulting from a disturbed microbial community and treatment and patient support options for these conditions
03/08/2023
CDOWST
Pharmaceuticals used to maintain health or restore health to a human subject via treatment of a disturbed microbial community, namely, for the treatment of dysbiosis and clostridium difficile; biological preparations in the nature of microorganisms used to maintain health or restore health to a human subject via treatment of a disturbed microbial community, namely, for the treatment of dysbiosis and clostridium difficile; cultures and preparations of microorganisms for medical purposes; pharmaceuticals and biological preparations used to prevent and treat dysbiosis and other medical conditions resulting from a disturbed microbial community
10/14/2020
CDRUPTEV
Pharmaceuticals used to maintain health or restore health to a human subject via treatment of a disturbed microbial community, namely, for the treatment of dysbiosis and clostridium difficile; biological preparations in the nature of microorganisms used to maintain health or restore health to a human subject via treatment of a disturbed microbial community, namely, for the treatment of dysbiosis and clostridium difficile; cultures and preparations of microorganisms for medical purposes; pharmaceuticals and biological preparations used to prevent and treat dysbiosis and other medical conditions resulting from a disturbed microbial community
10/14/2020

See all trademarks and details in the Full Report.


Recession Risk

Determine whether Seres Therapeutics grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Seres Therapeutics is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



U.S. Industry Overview & Market Statistics:
Telecommunications

Publisher: AnythingResearch

  • Market Size
  • Growth Rate
  • 5-Year Market Forecast
  • Average Company Size & Growth
  • Salary & Compensation Benchmarks



Market Share of Seres Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Seres Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
AT & TDallas, TX100 
VERIZON COMMUNICATIONSNew York, NY57 
CCO HOLDINGSSaint Louis, MO55 
T-MOBILE USABellevue, WA46 
QUALCOMMSan Diego, CA34 
DIRECTVEl Segundo, CA34 
LUMEN TECHNOLOGIESMonroe, LA15 
NATIONAL TELECOMMUNICATIONS COOPERATIVE ASSOCIATIONArlington, VA13 




Nearby Competitors

These companies are similar in business line and location to Seres Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
GRANITE TELECOMMUNICATIONSQuincy, MA100 
SERES THERAPEUTICSCambridge, MA21 
STARRYBoston, MA10 
COMNISCIENT TECHNOLOGIESBoston, MA8 
TIVECharlestown, MA5 
ALTAEROS ENERGIESSomerville, MA2 




Future Competition: Seres Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Seres Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Seres Therapeutics Competitors